Salem Investment Counselors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20.7M Buy
192,941
+95
+0% +$10.2K 0.66% 30
2025
Q1
$19.5M Sell
192,846
-3,944
-2% -$398K 0.68% 31
2024
Q4
$17.6M Sell
196,790
-15,857
-7% -$1.42M 0.58% 37
2024
Q3
$17.8M Buy
212,647
+768
+0.4% +$64.4K 0.54% 39
2024
Q2
$16.3M Buy
211,879
+661
+0.3% +$50.9K 0.53% 38
2024
Q1
$14.5M Buy
211,218
+23,324
+12% +$1.6M 0.48% 41
2023
Q4
$10.9M Sell
187,894
-10,360
-5% -$599K 0.37% 47
2023
Q3
$10.5M Buy
198,254
+8,892
+5% +$469K 0.4% 45
2023
Q2
$10.2M Buy
189,362
+25
+0% +$1.35K 0.37% 47
2023
Q1
$9.47M Sell
189,337
-6,988
-4% -$350K 0.38% 48
2022
Q4
$9.08M Buy
196,325
+900
+0.5% +$41.6K 0.39% 45
2022
Q3
$7.57M Buy
195,425
+11,400
+6% +$442K 0.34% 50
2022
Q2
$6.86M Buy
184,025
+30,419
+20% +$1.13M 0.31% 55
2022
Q1
$6.8M Buy
153,606
+250
+0.2% +$11.1K 0.27% 61
2021
Q4
$6.52M Buy
153,356
+5,115
+3% +$217K 0.23% 67
2021
Q3
$6.43M Buy
148,241
+6,400
+5% +$278K 0.35% 59
2021
Q2
$6.07M Buy
141,841
+1,400
+1% +$59.9K 0.33% 67
2021
Q1
$5.43M Sell
140,441
-2,088
-1% -$80.7K 0.33% 67
2020
Q4
$5.12M Buy
142,529
+4,513
+3% +$162K 0.34% 66
2020
Q3
$5.27M Hold
138,016
0.4% 59
2020
Q2
$4.85M Buy
138,016
+170
+0.1% +$5.97K 0.41% 56
2020
Q1
$4.5M Buy
137,846
+1,105
+0.8% +$36.1K 0.47% 54
2019
Q4
$6.18M Sell
136,741
-445
-0.3% -$20.1K 0.51% 51
2019
Q3
$5.58M Sell
137,186
-1,250
-0.9% -$50.9K 0.51% 50
2019
Q2
$5.95M Buy
138,436
+545
+0.4% +$23.4K 0.55% 47
2019
Q1
$5.31M Buy
137,891
+1,920
+1% +$73.9K 0.54% 47
2018
Q4
$4.81M Sell
135,971
-1,920
-1% -$67.9K 0.61% 44
2018
Q3
$5.31M Sell
137,891
-600
-0.4% -$23.1K 0.54% 47
2018
Q2
$4.53M Sell
138,491
-450
-0.3% -$14.7K 0.41% 52
2018
Q1
$3.73M Buy
138,941
+66
+0% +$1.77K 0.42% 60
2017
Q4
$3.44M Buy
138,875
+13,700
+11% +$340K 0.37% 65
2017
Q3
$3.68M Buy
125,175
+8,802
+8% +$259K 0.43% 59
2017
Q2
$3.23M Buy
116,373
+13,973
+14% +$387K 0.37% 63
2017
Q1
$2.55M Sell
102,400
-11,446
-10% -$285K 0.27% 89
2016
Q4
$2.46M Buy
113,846
+20,271
+22% +$438K 0.28% 82
2016
Q3
$22.3K Buy
93,575
+64,575
+223% +$15.4K 0.29% 81
2016
Q2
$678K Buy
+29,000
New +$678K 0.08% 157